Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators

Molecular Endocrinology

Volumn 13, Issue 6, 1999, Pages 897-909

  Lopez, Gabriela N ^a   Webb, Paul ^a   Shinsako, Jeanette H ^a   Baxter, John D ^a   Greene, Geoffrey L ^b   Kushner, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN RECEPTOR; GLUCOCORTICOID; PROGESTERONE RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; DNA FLANKING REGION; LIGAND BINDING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TITRIMETRY; TRANSCRIPTION INITIATION;

EID: 0033305094     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.6.0283     Document Type: Article

References (70)

1. Nuclear receptors in Sicily: All in the famiglia
2. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
3. The nuclear hormone receptor gene superfamily
4. Nuclear hormone receptors: Ligand-activated regulators of transcription and diverse cell responses
5. The human estrogen receptor has two independent nonacidic transcriptional activation functions
6. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen
7. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
8. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation
9. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells
10. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists
11. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
12. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor
13. Functional analysis of a transactivation domain in the thyroid hormone beta receptor
14. Steroid hormone receptors compete for factors that mediate their enhancer function
15. Distinct classes of transcriptional activating domains function by different mechanisms
16. Interaction of proteins with transcriptionally active estrogen receptors
17. Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription
18. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
19. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
20. Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator
21. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors
22. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
23. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
24. The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function
25. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
26. TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1
27. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
28. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
29. Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity
30. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
31. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
32. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors
33. A regulatory role for RIP140 in nuclear receptor activation
34. Role of CBP/P300 in nuclear receptor signalling
35. p300 Is a component of an estrogen receptor coactivator complex
36. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300
37. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription
38. Nuclear receptor coactivators
39. p300, and p300-Associated proteins, are components of TATA-binding protein (TBP) complexes
40. CREB-binding protein activates transcription through multiple domains
41. Nuclear protein CBP is a coactivator for the transcription factor CREB
42. The transcriptional coactivators p300 and CBP are histone acetyltransferases
43. The CBP co-activator is a histone acetyltransferase
44. Steroid receptor coactivator-1 is a histone acetyltransferase
45. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
46. Transcription factor-specific requirements for coactivators and their acetyltransferase functions
47. p300 and Estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation
48. Acetylation of general transcription factors by histone acetyltransferases
49. RIP 140 enhances nuclear receptor-dependent transcription in vivo in yeast
50. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
51. Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy
52. Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein
53. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action
54. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
55. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
56. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
57. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2
58. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties
59. Functional domains of the human estrogen receptor
60. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
61. Retinoic acid and thyroid hormone induce gene expression through a common responsive element
62. Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site
63. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element
64. Monoclonal antibodies to human estrogen receptor
65. Human estrogen receptor bound to an estrogen response element bends DNA
66. Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli
67. A potent specific pure antiestrogen with clinical potential
68. Quantitation of submicrogram quantities of protein by an improved protein-dye binding assay
69. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens
70. The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins